Societal CDMO Inc
NASDAQ:SCTL
Societal CDMO Inc
Cash from Financing Activities
Societal CDMO Inc
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Societal CDMO Inc
NASDAQ:SCTL
|
Cash from Financing Activities
$2.3m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
12%
|
|
Johnson & Johnson
NYSE:JNJ
|
Cash from Financing Activities
-$15.8B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-7%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Cash from Financing Activities
-$9.4B
|
CAGR 3-Years
-101%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-24%
|
|
Pfizer Inc
NYSE:PFE
|
Cash from Financing Activities
$26.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Cash from Financing Activities
-$4.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
18%
|
CAGR 10-Years
2%
|
|
Eli Lilly and Co
NYSE:LLY
|
Cash from Financing Activities
$3.5B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Societal CDMO Inc's Cash from Financing Activities?
Cash from Financing Activities
2.3m
USD
Based on the financial report for Dec 31, 2023, Societal CDMO Inc's Cash from Financing Activities amounts to 2.3m USD.
What is Societal CDMO Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
12%
Over the last year, the Cash from Financing Activities growth was 32%. The average annual Cash from Financing Activities growth rates for Societal CDMO Inc have been -17% over the past three years , -39% over the past five years , and 12% over the past ten years .